Quick Answer
cbdMD, Inc. reported Net Income Loss of -$2.04 million for the year ending 2025.
- cbdMD, Inc. showed an increase of +44.8% in Net Income Loss from 2024 to 2025.
- This data is from cbdMD, Inc.'s annual report (Form 10-K), filed with the SEC on December 19, 2025.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2016: -$697.5 thousand | Q1 2017: -$288.2 thousand | Q2 2017: -$141.9 thousand | Q4 2017: -$1.26 million | Q1 2018: $1.64 million | Q2 2018: $565.3 thousand | Q4 2018: -$2.19 million | Q1 2019: -$31.85 million | Q2 2019: -$29.20 million | Q4 2019: $12.93 million | Q1 2020: $14.88 million | Q2 2020: -$8.95 million | Q3 2020: -$6.26 million | Q4 2020: -$9.40 million | Q1 2021: -$12.51 million | Q2 2021: $1.54 million | Q3 2021: -$2.92 million | Q4 2021: -$19.16 million | Q1 2022: -$4.66 million | Q2 2022: -$31.63 million | Q3 2022: -$14.63 million | Q4 2022: -$3.96 million | Q1 2023: -$1.34 million | Q2 2023: -$1.77 million | Q3 2023: -$15.87 million | Q4 2023: -$996.5 thousand | Q1 2024: -$3.01 million | Q2 2024: $459.7 thousand | Q3 2024: -$152.8 thousand | Q4 2024: $15.1 thousand | Q1 2025: -$480.8 thousand | Q2 2025: -$895.3 thousand | Q4 2025: -$283.1 thousand.
- Over the full 10 years of available data (2016 to 2025), cbdMD, Inc.'s Net Income Loss has grown by 47.6%.
- Historical annual values: Fiscal year 2025: -$2.04 million | Fiscal year 2024: -$3.70 million | Fiscal year 2023: -$22.94 million | Fiscal year 2022: -$70.08 million | Fiscal year 2021: -$23.39 million | Fiscal year 2020: $12.60 million | Fiscal year 2019: -$51.36 million | Fiscal year 2018: $62.8 thousand | Fiscal year 2017: -$1.39 million | Fiscal year 2016: -$3.90 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: